Literature DB >> 9301609

Sestamibi scanning is inadequate for directing unilateral neck exploration for first-time parathyroidectomy.

W Shen1, U Sabanci, E T Morita, A E Siperstein, Q Y Duh, O H Clark.   

Abstract

OBJECTIVE: To determine whether technetium Tc 99m sestamibi scanning is accurate enough to allow surgeons to perform unilateral neck exploration for first-time parathyroidectomy in patients with primary hyperparathyroidism.
DESIGN: Retrospective review.
SETTING: University tertiary care center. PATIENTS: Forty patients with primary hyperparathyroidism who underwent sestamibi scanning before first-time parathyroidectomy, of whom 28 had single adenomas, 9 had multiple adenomas, and 3 had hyperplasia.
INTERVENTIONS: All 40 patients underwent bilateral neck exploration with identification of 4 parathyroid glands. MAIN OUTCOME MEASURES: We compared the results of preoperative sestamibi scanning with operative and histologic findings. We then used these data to calculate the projected success rates of parathyroidectomy if unilateral neck explorations had been performed based on the results of sestamibi scanning, instead of bilateral explorations.
RESULTS: Sestamibi scanning was correct in 20 (71%) of 28 patients with single adenomas, 4 (44%) of 9 patients with multiple adenomas, and 0 (0%) of 3 patients with hyperplasia. If unilateral neck explorations had been performed on the basis of localization by sestamibi scanning, parathyroidectomy would have failed in 4 (10%) of 40 patients.
CONCLUSIONS: Sestamibi scanning, although helpful, is inadequate for directing unilateral neck exploration for first-time parathyroidectomy. Surgeons who perform unilateral neck exploration based on the results of sestamibi scanning will record a higher failure rate and incur higher costs than those who perform bilateral neck exploration for first-time parathyroidectomy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9301609     DOI: 10.1001/archsurg.1997.01430330035005

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  8 in total

1.  Primary hyperparathyroidism: is there a role for imaging? (Pro).

Authors:  Rudolf Roka; Michael Pramhas; Sebastian Roka
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-31       Impact factor: 9.236

2.  The false-positive parathyroid sestamibi: a real or perceived problem and a case for radioguided parathyroidectomy.

Authors:  J G Norman; C E Jaffray; H Chheda
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

3.  Accuracy of surgeon-performed ultrasound in parathyroid localization.

Authors:  Russell Van Husen; Lawrence T Kim
Journal:  World J Surg       Date:  2004-11       Impact factor: 3.352

4.  Intrinsic limitations to unilateral parathyroid exploration.

Authors:  F D Moore; F Mannting; M Tanasijevic
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

5.  Bilateral neck exploration under hypnosedation: a new standard of care in primary hyperparathyroidism?

Authors:  M Meurisse; E Hamoir; T Defechereux; L Gollogly; O Derry; A Postal; J Joris; M E Faymonville
Journal:  Ann Surg       Date:  1999-03       Impact factor: 12.969

6.  Preoperative evaluation of parathyroid lesions in patients with concomitant thyroid disease: role of high resolution ultrasonography and dual phase technetium 99m sestamibi scintigraphy.

Authors:  M Kebapci; E Entok; N Kebapci; B Adapinar
Journal:  J Endocrinol Invest       Date:  2004-01       Impact factor: 4.256

7.  Intraoperative jugular venous sampling AIDS detection of an undescended parathyroid adenoma.

Authors:  Lawrence S Lee; Robert J Canter; Douglas L Fraker
Journal:  World J Surg       Date:  2006-04       Impact factor: 3.352

8.  (99m)Technetium Sestamibi-(123)Iodine Scintigraphy Is More Accurate Than (99m)Technetium Sestamibi Alone before Surgery for Primary Hyperparathyroidism.

Authors:  Eeva M Ryhänen; Jukka Schildt; Ilkka Heiskanen; Mika Väisänen; Aapo Ahonen; Eliisa Löyttyniemi; Camilla Schalin-Jäntti; Matti J Välimäki
Journal:  Int J Mol Imaging       Date:  2015-02-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.